AI-26 OVERCOMING RESISTANCE TO VEGF-BLOCKADE BY TARGETING THE ANGIOPOIETIN/TIE2 AXIS

Angiogenesis inhibitors have evolved in the past decade as one of the most promising biology based therapeutic strategies. Pre-clinical studies (published in 1993 and 1994) provided proof of principle that blocking of VEGF dramatically inhibits tumor growth. These observations led to the successful...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Scholz, Alexander, Cremer, Sebastian, Harter, Patrick, Mittelbronn, Michel, van Slyke, Paul, Dumont, Dan, Plate, Karl H.
Formato: Artigo
Lenguaje:Inglês
Publicado: Oxford University Press 2014
Materias:
Abstracts
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4217865/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou238.26
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares